New York City, NY: Jun 20, 2019 – Published via (Wired Release) – Veterinary therapeutic is medical science deals with the protection of health, alleviation, prevention, and remedy of disease and injury in both companion as well as wild animals. The global veterinary therapeutics market has witnessed significant revenue growth in the past few years owing mainly to rising awareness regarding health and well-being of livestock as well as companion animals.
The first five-year cumulative revenue (2017–2021) is projected to be US$ 154,050.2 Mn, which is expected to increase rather significantly over the latter part of the five-year forecast period. The global veterinary therapeutics market is projected to reach a value of over US$ 900 Mn in 2026 at a CAGR of 23.2% over the forecast period.
Major factors driving growth of the global veterinary therapeutics market are increasing awareness of animal well-being, increasing ownership of companion animals, constant development of innovative drugs, and increasing clinical pet research initiatives and programs resulting in launch of wide variety of vaccines and medicines in the market.
Request For Sample Report Before Buying (Use Corporate eMail ID to Get Higher Priority): https://marketresearch.biz/report/veterinary-therapeutics-market/request-sample/
Global Veterinary Therapeutics Market: Market Forecast
The comprehensive research report comprises a complete forecast of the global veterinary therapeutics market based on factors affecting the market and their impact in the foreseeable future. According to the forecast projections, revenue from the global veterinary therapeutics market is expected to expand at a moderate CAGR of 6.0% during the forecast period.
Global Veterinary Therapeutics Market: Segmental Snapshot
The market report has been segmented on the basis of type, end user, and region. The type segment includes therapeutic drugs, therapeutic vaccines, and feed additive therapeutic. End-user segment includes hospitals, veterinary clinics, and drug stores. The regions covered in the analysis are The Americas, Europe, Asia Pacific, South America, and Middle East & Africa.
By type: Therapeutic drugs segment is estimated to register a CAGR of over 6.2%, thereby accounting for highest revenue share in the application segment.
By end-user: Hospitals segment is estimated to account for highest revenue share among the product type segments, registering a CAGR of over 6.3% over the forecast period.
By region: The market in North America accounted for highest revenue share in the global veterinary therapeutics market in 2016, and is expected to record highest CAGR of over 5.9% between 2017 and 2026.
Inquire for Further Detailed Information About The Report Before Buying (Use Corporate email ID to Get Higher Priority): https://marketresearch.biz/report/veterinary-therapeutics-market/#inquiry
Global Veterinary Therapeutics Market: Competitive Analysis
The research report on the global veterinary therapeutics market includes profiles of some of the major companies such as Bayer AG, Boehringer Ingelheim GmbH, Ceva, Inc., Dechra Pharmaceuticals PLC, Vetoquinol SA, Zoetis Inc., Virbac SA, Eli Lilly and Company, Merck Co. Inc., Pfizer Inc., Catalent Inc., Akorn Inc., Aratana Therapeutics, Inc., Heska Corporation, Abaxis, Inc., IDEXX Laboratories, Inc., Perrigo Company plc., NEOGEN CORPORATION, Colorado Serum Company, Piedmont Animal, Health LLC, and Addison Biological Lab, Inc.
Pricing Details For The Report: (Limited Period Offer) Single User- $3,995 | Multiple User- $6,600 | Corporate Users- $8,200
To Purchase This Premium Report Click Here: https://marketresearch.biz/purchase-report/?report_id=1951
How do Single user, multiple user, and corporate licenses differ from each other?
Single user, multiple user, and corporate licenses are differentiated on the basis of the number of users permitted to use the ordered reports. For a single user license, the distribution of a report copy will be restricted to only one user. Understood by its term, a multiple user license will be restricted to more than one user, typically five users only. Corporate license holders, on the other hand, will be able to distribute a report copy across their organization.
About Us:
MarketResearch.Biz is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. It offers services such as data mining, information management, and revenue enhancement solutions and suggestions.
Contact Us:
Mr. Benni Johnson
Prudour Pvt. Ltd.
420 Lexington Avenue,
Suite 300 New York City, NY 10170,
United States
Tel: + 1-347-826-1876
Email ID: inquiry@marketresearch.biz
Website: https://marketresearch.biz/
from Wired Release http://bit.ly/2ZyJHNL
via gqrds
No comments:
Post a Comment